China · Who invested in BeiGene?
BeiGene's investors include Hillhouse Capital Group, Fidelity, T. Rowe Price, Rock Springs Capital and CITIC Capital Holdings.
2015
$75MSeries A$97MSeries BChina · Series B startup
Who invested in BeiGene
2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$172Mraised across 2 rounds since 2014, from 2 sources
$75MSeries A$97MSeries B
- Latest round
- Series B, $97MMay 2015
- Step-upi
- 1.3×
- Investors
- 5
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $75M Nov 2014
- Biggest round
- $97M Series B · May 2015
- Between rounds
- 6 months from the last two
The rounds
- May 2015Series B$97M3 new1 returning
From a historical funding record
- Nov 2014
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Series A2014Series B2015Hillhouse Capital GroupFidelity
T. Rowe Price
Rock Springs Capital
CITIC Capital Holdings
T. Rowe PriceRock Springs CapitalCITIC Capital HoldingsEveryone who backed them
Hillhouse Capital GroupPrivate equity2rounds
FidelityVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about BeiGene
How much has BeiGene raised?
BeiGene has raised $172M across 2 rounds since 2014.
When did BeiGene last raise?
BeiGene's most recent round was a Series B of $97M in May 2015.
What was BeiGene's biggest round?
Its most recent round, $97M in May 2015, is also its largest on record.
Who backed BeiGene first?
BeiGene's first round on record, in Nov 2014, was backed by Hillhouse Capital Group and CITIC Capital Holdings.
What stage is BeiGene at?
BeiGene's latest named round is a Series B, in May 2015.
Where is BeiGene based?
BeiGene is based in China.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.